Doctor profile · Federal record
Dr. CANDACE KOIRTH, ARNP
Adult Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · PRATT, KS
- NPI 1710082508
- Accepts Medicare
- MIPS 67.4 / 100 · 2023
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
124 COMMODORE ST STE A
PRATT, KS 671242994
(620) 508-6025
fax (620) 508-6415
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- April 2, 2026
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Kansas #45129
- Medicaid
- KS #100416640A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710082508. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,862
Distinct HCPCS
10
Medicare allowed
$139,325
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0185 |
Injection, aprepitant, 1 mg | 5,980 | 13 | $2 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 3,200 | 12 | $6 | |
J0897 |
Injection, denosumab, 1 mg | 3,120 | 12 | $24 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 752 | 19 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 135 | 86 | $72 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 128 | 22 | $23 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 123 | 32 | $101 | |
96372 |
Injection of drug or substance under skin or into muscle | 104 | 35 | $11 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 81 | 14 | $22 | |
99441 |
Telephone medical discussion with physician, 5-10 minutes | 64 | 55 | $44 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 990. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$2,087
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 7 | $211.98 | |
| AstraZeneca Pharmaceuticals LP | 8 | $199.39 | |
| Janssen Biotech, Inc. | 8 | $192.03 | |
| Apellis Pharmaceuticals, Inc. | 6 | $165.52 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $125.63 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $109.38 | |
| Novartis Pharmaceuticals Corporation | 6 | $100.13 | |
| PFIZER INC. | 6 | $93.73 | |
| Genentech USA, Inc. | 5 | $93.60 | |
| GlaxoSmithKline, LLC. | 5 | $91.38 | |
| Daiichi Sankyo Inc. | 4 | $67.97 | |
| Celgene Corporation | 3 | $61.52 | |
| Sumitomo Pharma America, Inc. | 3 | $53.40 | |
| ABBVIE INC. | 2 | $49.77 | |
| Incyte Corporation | 3 | $48.92 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
390
Patients
42
Total drug cost
$293,261
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 95 | 14 | $1,749 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 52 | 15 | $3,064 |
| Ondansetron Hcl | Generic | 31 | 13 | $765 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 28 | 0 | $920 |
| Tamoxifen Citrate | Generic | 25 | 0 | $417 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 19 | 0 | $590 |
| Morphine Sulfate Er (Morphine Sulfate) | Brand | 18 | 0 | $370 |
| Oxycodone Hcl | Generic | 18 | 0 | $311 |
| Hydroxyzine Hcl | Generic | 17 | 0 | $101 |
| Fentanyl | Generic | 16 | 0 | $796 |